SCARB1 and lymphoma: Only recently, the biomimetic synthetic HDLs containing a gold nanocrystalline core have proven successful in the treatment of lymphoma by inhibiting B-cell lymphoma growth through binding to SR-B1, cholesterol starvation and selective induction of apoptosis [130].